, , ,
A new study in the British Journal of Clinical Pharmacology, suggests that the link between the development of type 2 diabetes and the use of statin drugs are stronger than previously thought. This strong link means that statin use may increase the risk of developing type 2 diabetes.
Drugmaker Eli Lilly announced their plans to sell a half-priced version of Humalog. All this in an effort to fend off criticism for their continued insulin price hikes in the US. Lilly and other major drug companies have been under fire lately for unnecessary price increases of insulin.
Patients notched a rare win over the pharmaceutical industry Monday when the Nevada Legislature revived a bill requiring insulin makers to disclose the profits they make on the life-sustaining drug. In a handful of other states, bills addressing drug prices have stalled.
Many of the 1.25 million Americans who live with Type 1 diabetes cheered the legislative effort in Nevada as an important first step in their fight against skyrocketing costs of a drug on which their lives depend. The cost of insulin medications has steadily risen over the past decade by nearly 300 percent.
As if people with diabetes don’t already have enough to worry about, now two major drug manufacturers decided to raise the price of their insulin. The rise in price is just another way to increase profit for Eli Lilly and Novo Nordisk, but for diabetics, the increase can be devastating and dangerous. Drug companies know that patients can’t just stop taking their medication. For people with type 1 diabetes not being able to afford their prescription is a matter of life and death.
Urinary incontinence UI is a problem that an estimated 20-25% of women face. Losing some or all control over one's bladder can be distressing and reduce a person's quality of life. There have been many studies on the correlation between urinary incontinence and diabetes in women, but they all seemed to fall short in some way.
Work was published today in Nature Medicine and Nature Biotechnology about a new device that shields insulin-producing beta cells from being destroyed by the immune system. In mice, the device lasted 6 months. This research brings new promise to a potential cure for type 1 diabetics and some type 2 insulin dependent diabetics.
For years, researchers have been trying to find a way to implant beta cells into patients with type 1 diabetes. Unfortunately, the patient’s own immune system attacks the beta cells, in the same manner as it had originally to cause them to have diabetes in the first place. This new device would potentially protect the beta cell and shield it from their immune system.
Researchers are in their final two phases of international trials to determine if type 1 diabetics can maintain their blood sugar levels with the help of a smartphone. The system will be used with a wearable blood glucose sensor that will automatically test their blood sugar every 5 minutes and report back to an app on the phone. The app uses an algorithm to analyze the given data that will then transmit to the patient's pump. Patient’s will no longer need to test their blood sugar and manually enter the information into their device.
For more information on the subject here's an article and a video you can check out.